| 000 | 01229 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514162027.0 | ||
| 264 | 0 | _c20040106 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a1472-8214 | ||
| 024 | 7 |
_a10.1517/14728214.8.1.1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCrosby, Colin G | |
| 245 | 0 | 0 |
_aThe cyclooxygenase-2 pathway as a target for treatment or prevention of cancer. _h[electronic resource] |
| 260 |
_bExpert opinion on emerging drugs _cMay 2003 |
||
| 300 |
_a1-7 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCyclooxygenase 2 |
| 650 | 0 | 4 | _aCyclooxygenase 2 Inhibitors |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMembrane Proteins |
| 650 | 0 | 4 |
_aNeoplasms _xenzymology |
| 650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aDuBois, Raymond N | |
| 773 | 0 |
_tExpert opinion on emerging drugs _gvol. 8 _gno. 1 _gp. 1-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14728214.8.1.1 _zAvailable from publisher's website |
| 999 |
_c14348250 _d14348250 |
||